Phase
Condition
Multiple Sclerosis
Enuresis
Scar Tissue
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
At least 3 episodes of urinary incontinence over a 3-day period
History of Multiple Sclerosis (MS)
Urinary incontinence not adequately controlled by anticholinergic medication
Exclusion
Exclusion Criteria:
Current use of intermittent catheter or indwelling catheter to manage urinaryincontinence
Previous or current botulinum toxin therapy of any serotype for any urologicalcondition
Previous or current botulinum toxin therapy of any serotype for any non-urologicalcondition within the last 12 weeks
Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, or Amyotrophic LateralSclerosis
Study Design
Connect with a study center
Liege,
BelgiumSite Not Available
Victoria, British Columbia
CanadaSite Not Available
Kitchener, Ontario
CanadaSite Not Available
Olomouc,
CzechiaSite Not Available
Garches,
FranceSite Not Available
Marseille,
FranceSite Not Available
Warsaw,
PolandSite Not Available
empty
Wroclaw,
PolandSite Not Available
Porto,
PortugalSite Not Available
empty
Moscow,
Russian FederationSite Not Available
St. Petersburg,
Russian FederationSite Not Available
Mountlake Terrace, Washington
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.